PATENT CLAIM ANALYSIS

Application Number: 16178041
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["424", "451000"]

Abstract:
A pharmaceutical composition for oral delivery is provided with a poorly water-soluble drug; solvent with lipophilic tails and hydrophilic ends; an acid initiator; and a foaming agent generating carbon dioxide bubbles when the acid initiator is dissolved into the intestinal fluid to form an acidic environment. The poorly water-soluble drug is dissolved in the solvent to form a self-assembled monolayer carrier system with the bile salts surrounding the carbon dioxide bubbles in water when the pharmaceutical composition is dissolved in an intestinal tract, and lipid oil drops containing the poorly water-soluble drug form when the carbon dioxide bubbles burst at the air-liquid interface in the intestinal tract.

Claim (Index 4):
The pharmaceutical composition for oral delivery according to  claim 1 , wherein the acid initiator comprises organic acid anhydrides or organic acids.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 98.0
- Lexical Diversity: 1.88333
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['10973644', '13575547', '15410448', '14754503', '14653071']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7304155712531393
- 35 USC 102 Novelty (BERT): 0.490896902055968
- Combined Prediction Score: 0.7064637043334222
- Mean Citation Score: 203.903836
- Max Citation Score: 214.85838
- Similarity Product: 156.12726436143282

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test